Back to results
US 4,447,545 AGranted
Bladder cancer detection
AssigneeNew England Deaconess Hospital Corporation
InventorsSally R. DeFazio, James J. Gozzo, Anthony P. Monaco
Life of this patent
Estimating the term…
Abstract
Disclosed is a technique for screening populations to detect potential bladder cancer patients. The screening test is based on a discovered correlation between the respective ratios of C-reactive protein to total protein in urine and serum and the incidence of bladder cancer.
Claims10
A method for screening a patient for the presence of a bladder carcinoma, said method comprising the steps of:
- (A) assaying for the ratio of C-reactive protein to total protein in a sample of the urine of said patient;
- (B) assaying for the ratio of C-reactive protein to total protein in a sample of the serum of said patient;
- and
- (C) comparing the ratio determined by assay in step A to the ratio determined by assay in step B, whereby
- (i) a finding of the absence of C-reactive protein in said urine sample is indicative of the absence of a bladder carcinoma;
- and
- (ii) a finding that the ratio determined in step A is greater than the ratio determined in step B is indicative of the presence of a bladder carcinoma.
4 more elements
Dependencies are inferred from the claim text.